Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

• Main Authors: Zijian Zhou (Author), Takuya Nagashima (Author), Chihiro Toda (Author), Mone Kobayashi (Author), Takahide Suzuki (Author), Kazuki Nagayasu (Author), Hisashi Shirakawa (Author), Satoshi Asai (Author), Shuji Kaneko (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Olanzapine is an atypical antipsychotic drug that is clinically applied in patients with schizophrenia. It increases the risk of dyslipidemia, a disturbance of lipid metabolic homeostasis, usually characterized by increased low-density lipoprotein (LDL) cholesterol and triglycerides, and accompanied...